Characterization of the visceral and neuronal phenotype of 4L/PS-NA mice modeling Gaucher disease-Reference-Cited by-同舟云学术

Characterization of the visceral and neuronal phenotype of 4L/PS-NA mice modeling Gaucher disease

Published:2020-01-13 Issue:1 Volume:15 Page:e0227077
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Schiffer Victoria,Santiago-Mujika Estibaliz,Flunkert Stefanie^ORCID,Schmidt Staffan,Farcher Martina,Loeffler Tina,Schilcher Irene,Posch Maria,Neddens Joerg,Sun Ying,Kehr Jan,Hutter-Paier Birgit

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference48 articles.

1. Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease;E Sidransky;The New England journal of medicine,2009

2. Glucocerebrosidase is present in alpha-synuclein inclusions in Lewy body disorders;O Goker-Alpan;Acta neuropathologica,2010

3. A Review of Gaucher Disease Pathophysiology, Clinical Presentation and Treatments;J Stirnemann;International journal of molecular sciences,2017

4. The clinical management of Type 2 Gaucher disease;K Weiss;Molecular genetics and metabolism,2015

5. Prosaposin: threshold rescue and analysis of the "neuritogenic" region in transgenic mice;Y Sun;Molecular genetics and metabolism,2002

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. AAV delivery ofGBA1suppresses α-synuclein accumulation in Parkinson’s disease models and restores motor dysfunction in a Gaucher’s disease model;2024-06-26

2. A New Target of Electroacupuncture Pretreatment Mediated Sympathetic Nervous to Improve MIRI: Glutamatergic Neurons in Fastigial Nucleus of the Cerebellum;Neuroscience;2023-12

3. Targeting neuronal lysosomal dysfunction caused by β-glucocerebrosidase deficiency with an enzyme-based brain shuttle construct;Nature Communications;2023-04-12

4. Treatment of a genetic brain disease by CNS-wide microglia replacement;Science Translational Medicine;2022-03-16

5. Applications of iPSCs in Gaucher Disease and other rare sphingolipidoses;iPSCs - State of the Science;2022